Gustav Fischer, MD
Adult Reconstructive Orthopaedic Surgery · Portland, ORNPI 1255590964
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,100 of the $24,356 with a category attached, or 70.2%. Stryker accounts for 97.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $6,751 and has fallen 74.7% since, to $1,706 in 2025.
Across 75 payments — averaging $324.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$24K
- Zimmer Biomet$441
- Smith+Nephew$120
- Medacta USA, Inc.$112
- Ossur Americas, Inc.$20
What the payments were for
- Consulting fees$17,10070%
- Travel & lodging$2,41010%
- Food & beverage$4,84620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 65 | $23,663 |
| Zimmer Biomet | 5 | $441 |
| Smith+Nephew | 3 | $120 |
| Medacta USA, Inc. | 1 | $112 |
| Ossur Americas, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,356 in reported general payments places this provider in the 80th percentile of 20 adult reconstructive orthopaedic surgery providers in Oregon.
See all adult reconstructive orthopaedic surgery providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 185 | $1,315 |
| Cefdinir | 62 | $609 |
| Tranexamic Acid | 22 | $536 |
| Diclofenac Sodium | 13 | $514 |
| Cephalexin | 60 | $437 |
| Tramadol Hcl | 63 | $289 |
| Hydromorphone Hcl | 31 | $249 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $208 |
| Ondansetron OdtOndansetron | 34 | $207 |
| Gabapentin | 12 | $155 |
| Naproxen | 33 | $133 |
| Meloxicam | 16 | $100 |
| Ondansetron Hcl | 17 | $100 |
| Doxycycline Hyclate | 12 | $82 |
| Prednisone | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Portland
- Ryland KaganPortland$154K
- Thomas HuffPortland$95K
- Lily WoodPortland$14K
- Adam BarmadaPortland$2K
- Kathryn SchabelPortland$444
- James VanhorneGrants Pass$42K
- James HoMedford$15K
- Daniel CowleyGrants Pass$12K
- Jessica PhillipsBeaverton$12K
- Mary SkrzynskiBend$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.